Beckwith-Cohen and colleagues report on successful gene augmentation therapy in a naturally occurring large-animal dog model of cone-rod synaptic disorder due to a mutation in CaBP4. Affected dogs exhibit synaptic immaturity and disorganization, which are rescued even in later stages of the disease supporting significant retinal plasticity.
